Les publications les plus percutantes de la semaine dans 29 spécialités, sélectionnées par IA
Dernière mise à jour: 11 mai 2026
Publié: 2026-12-01
Annals of medicine
MediLens Indexé: 2026-05-12
This study investigates the variation in ischemic stroke admissions among patients with atrial fibrillation (AF) based on the day of the week. Analyzing data from the nationwide FinACAF study, which included 13,781 patients with a mean age of 79.2 years, the results show significant differences i...
Lire sur PubMedPublié: 2026-05-11
Hypertension (Dallas, Tex. : 1979)
MediLens Indexé: 2026-05-12
The WISDOM-HMOD study evaluated the relationship between nighttime blood pressure measured by a wrist-type monitor and left ventricular hypertrophy in 1218 patients with hypertension or heart failure. Results showed an average nighttime systolic/diastolic BP of 110.5±13.0/63.5±8.8 mm Hg, with 70....
Lire sur PubMedPublié: 2026-05-11
Circulation. Heart failure
MediLens Indexé: 2026-05-12
This review addresses the significant advancements in cardiac gene therapy for cardiomyopathy, highlighting the transition of adeno-associated virus-mediated gene replacement into early-phase clinical trials. It notes improvements in biomarkers like NT-proBNP and discusses the challenges in deliv...
Lire sur PubMedPublié: 2026-05-11
Medical science monitor : international medical journal of experimental and clinical research
MediLens Indexé: 2026-05-12
This study evaluated the impact of a structured, multidisciplinary case management model on cardiac function and glycemic control in elderly patients with coronary heart disease and diabetes undergoing off-pump CABG. A total of 168 patients were randomized to receive either routine care or an enh...
Lire sur PubMedPublié: 2026-05-11
Cardiology in review
MediLens Indexé: 2026-05-12
This study highlights the critical role of sodium-glucose cotransporter 2 inhibitors and nonsteroidal mineralocorticoid receptor antagonists in reducing cardiovascular and kidney disease risks in patients with type 2 diabetes. Empagliflozin showed significant benefits in reducing cardiovascular m...
Lire sur PubMedDes médecins du monde entier commencent leur journée avec des revues de littérature par IA, livrées à 7h.
Essai gratuit de 14 jours